Larvol Delta - SmallMolecule-Inhibitors-Targeting-the-Canonical-WNT-Signaling-Pathway-for-the-Treatment-of-Cancer

PRI-724 - PRISM Pharma, Ohara Pharma

WNT974 - Novartis

ETC159 - Experimental Therapeutics Centre

http://www.ncbi.nlm.nih.gov/pubmed/33822624

Apr 7, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next